Conatus Pharmaceuticals OverviewConatus Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for CNAT.
Quarterly Other Income/Expense
$118000.00
↓ 41.87% YoY
As of Mar 31, 2020
Annual Other Income/Expense (TTM)
$536000.00
↑ 24.36% YoY
Trailing 12 months ending Mar 31, 2020